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Transient receptor potential (TRP) ion channels are
molecular gateways in sensory systems, an interface
between the environment and the nervous system.
Several TRPs transduce thermal, chemical, and me-
chanical stimuli into inward currents, an essential
first step for eliciting thermal and pain sensations.
Precise regulation of the expression, localization, and
function of the TRP channels is crucial for their sen-
sory role in nociceptor terminals, particularly after in-
flammation, when they contribute to pain hypersensi-
tivity by undergoing changes in translation and
trafficking as well as diverse posttranslational modifi-
cations.
Organisms are bombarded with stimuli from their exter-
nal and internal environments. These include temper-
ature, exposure to photons and protons, and mechani-
cal deformations as well as contact with a diverse
range of intrinsic and extrinsic chemicals. Sophisti-
cated sensory systems are essential for detecting envi-
ronmental changes. A particular requirement is to dif-
ferentiate potentially harmful from innocuous stimuli.
Intense tissue-damaging, or “noxious,” stimuli generate
a highly unpleasant sensation—pain—which minimizes
contact with the injurious stimulus, a key protective re-
sponse. Inflammation or tissue injury then heightens
pain sensitivity so that contact with the wounded body
part is limited until healing occurs.
Multiple molecules have been adapted over the
course of evolution to act as sensory transducers, each
specialized to respond only to particular aspects of the
environment, and initiate—directly or indirectly—action
potentials in sensory neurons. Collectively, these trans-
ducers encode the quality, intensity, duration, and tem-
poral properties of sensory stimuli contributing to the
exquisite specificity and differential sensitivity of our
sensory experience. Of these, TRP ion channels have
emerged as a major sensory transducer family, with
many members involved specifically in generating
chemically and thermally evoked pain sensations.
Multiple TRP genes have been identified, including
28 in the human genome, and almost all are nonselec-
tive cation channels with six transmembrane domains.
Based upon their sequence homology, TRPs are classi-
fied into six subfamilies. Many TRPs are expressed in
the nervous system, particularly in high-threshold noci-
ceptor sensory neurons, where their thermosensory
and chemosensory roles are key. TRPV1, TRPV2,*Correspondence: cwoolf@partners.orgTRPV3, TRPV4, and TRPM8 are thermoreceptors (see
Table 1); the role of another channel, TRPA1, as a cold
pain receptor remains disputed (Bandell et al., 2004;
Jordt et al., 2004). Between them, these TRPs are ex-
quisitely tuned to cover a range of temperature sensi-
tivities that encompass cold and hot pain as well as
innocuous cold and warmth. A further remarkable char-
acteristic of many TRP channels is their chemosensitiv-
ity, e.g., TRPV1’s sensitivity to capsaicin (the pungent
ingredient in chili peppers), protons, and endocannabi-
noids; TRPM8’s sensitivity to menthol; TRPA1’s sensi-
tivity to mustard (Jordt et al., 2004) and cinnamon oil
(Bandell et al., 2004); and TRPV3’s sensitivity to cam-
phor (Moqrich et al., 2005). For TRPV1, TRPV3, and
TRPM8, the sensations elicited by capsaicin, camphor,
and menthol correspond to their thermal transduction
properties, hot and cool, while TRPA1, a putative cold
receptor, generates a burning sensation when activated
by mustard oil or wasabi.
TRPV3 and TRPV4, two “innocuous” warm detectors,
are highly expressed in keratinocytes as well as in pri-
mary sensory dorsal root ganglion (DRG) neurons, and
as a result, keratinocytes can detect changes in tem-
perature in the warm range (Chung et al., 2004; Moqrich
et al., 2005). These skin cells may release ATP in re-
sponse to heat activation, which by binding to pu-
rinergic ion channel receptors on the peripheral ter-
minals of sensory neurons, could drive sensory inflow
in the nervous system. This model expands the sensory
apparatus from the nervous system to the skin!
How do noxious temperatures, low or high, activate
TRPM8 and TRPV1? It turns out that temperature sens-
ing is closely related to the voltage-dependent gating
properties of both channels; changes in temperature
produce shifts in their voltage-dependent activation
curves (Voets et al., 2004). Interestingly, menthol and
capsaicin work on TRPM8 and TRPV1 as gating modifi-
ers, shifting their activation curves toward the resting
membrane potential (Voets et al., 2004).
A sensory role for the TRPs in mammals beyond
thermo- and chemodetection has been revealed re-
cently: mechanotransduction. TRPA1 appears to be re-
sponsible for mechanotransduction in vertebrate hair
cells, contributing to hearing and equilibrium (Corey et
al., 2004). It is most unlikely to have a chemodetection
or a role in cold pain here. This finding raises the possi-
bility that TRPs may be mechanodetectors in the verte-
brate somatosensory system. Although the degenerin-
homologous family of acid-sensing ion channels (ASICs)
has been suggested to be cutaneous mechanotrans-
ducers, ASIC knockout studies (ASIC 2 and 3) (Roza et
al., 2004) do not show loss of mechanosensitivity. In
zebrafish and Drosophila, a TRP channel, NompC, is
essential for mechanosensation (Walker et al., 2000),
and another TRP channel, painless, with high homology
to TRPA1, is involved in mechanical nociception in Dro-
sophila (Tracey et al., 2003). Is TRPA1 also a mechano-
transducer in high-threshold mammalian nociceptor
sensory neurons, responsible for pinch and pinprick?
In spite of initial expectations that TRPV1 was the
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10Table 1. Mammalian Sensory TRPs
Channel Name Major Tissue Distribution Sensory Modality Regulatory Mechanism
TRPV Subfamily
TRPV1 DRG, trigeminal ganglia (TG), urinary T R 43°C, acid, capsaicin, (+) PKA, PKC, PI3K, p38, Src, PLC,
bladder resiniferatoxin, phorbol ester, PLA2/lipoxygenase, CaMKII, BK,
N-arachidonyl dopamine, NGF, PGE2, ATP, ethanol, nicotine,
arachidonic acid metabolites, acid, 2-APB
endocannabinoids, 2-
aminoethoxydiphenyl borate
(2-APB)
(−) PIP2, calmodulin, calcineurin,
adenosine
TRPV2 DRG, spinal cord (SC), brain, spleen, T R 52°C, 2-APB (+) translocation (by IGF-1)
intestine
TRPV3 DRG, TG, SC, brain, keratinocytes, T R 30°C–39°C, 2-APB, camphor (+) 2-APB, camphor
tongue
TRPV4 DRG, TG, brain, keratinocytes, kidney, T R 25°C, hypotonicity, noxious (+) PLA2/cytochrome P450, Src,
lung, spleen, testis, endothelium, mechanical stimulus, acid, PGE2
liver, heart, inner-ear hair cells phorbol ester,
endocannabinoids, arachidonic
acid metabolites
TRPM Subfamily
TRPM5 taste tissue, small intestine, liver, lung, taste (sweet, bitter, umami) (+) PLCβ2, intracellular Ca++, PIP2
TRPM8 DRG, TG, prostate T % 23°C–28°C, menthol, icilin, (+) PIP2
PIP2
(−) intracellular acidification, 2-APB
TRPA Subfamily
TRPA1 DRG, fibroblasts, hair cells T % 18°C, icilin, cannabinoids, (+) PLCβ
mustard oil, BK,
cinnamaldehyde, mechanical
stimulus (hair cells)
TRPC Subfamily
TRPC2 (pseudogene in Vomeronasal organ, testis, spleen, pheromone (mouse only) (+) DAG
human) liver, heart, brainheat pain transducer, TRPV1 knockout mice have mini- w
omal defects in noxious heat responses (Woodbury et
al., 2004). The TRPV1 null mutants do show, however, t
ca very substantial reduction in inflammatory pain hyper-
sensitivity (Caterina et al., 2000). A major role of this c
cand other TRP channels may therefore be to heighten
pain sensitivity in response to tissue injury. How do they m
sdo this?
Two major mechanisms contribute to inflammatory t
Tpain. One is the phenomenon of peripheral sensitiza-
tion, involving a reduction in the threshold and an in- (
fcrease in the responsiveness of the peripheral ter-
minals of nociceptors; the other is central sensitization, T
nan augmentation of synaptic transmission in the spinal
cord. TRPV1 has a major role in producing peripheral h
fsensitization, acting as the final substrate for multiple
inflammatory mediators that operate via distinct intra- b
scellular signaling pathways to reduce the heat pain
threshold from w42°C to close to body temperature.
cThis is responsible for the pain experienced in response
to a normally warm stimulus, as in a shower after a too- i
clong day at the beach. The contribution of other TRPs
to peripheral sensitization remains to be explored. n
rChanges in the transduction sensitivity and threshold
of nociceptors can occur by regulating the number, dis- T
ctribution, and activity of their transducers. Thus, pain
sensitivity is potentially influenced by regulation of TRP m
ggenes, their messenger RNAs and protein products, asell as multimer organization. Given the coexpression
f many TRP channels in nociceptors, there are oppor-
unities for heteromultimerization, but whether this oc-
urs and what functional consequences ensue are not
lear. Splice variants can control the activity of the
hannels by influencing their tetrameric composition. In
ouse dorsal root ganglia, there are two alternatively
pliced products of TRPV1: TRPV1α and TRPV1β. Al-
hough TRPV1β does not function alone, it reduces
RPV1α activity, acting as dominant-negative channel
Wang et al., 2004). Similar alternative splicing occurs
or TRPM1, leading to long and short isoforms. The
RPM1 short isoform cannot form functional ion chan-
els due to lack of transmembrane domains, but when
ereologously expressed, it blocks the trafficking of the
unctional long isoform from the cytoplasm to the mem-
rane. Do TRP splice variants contribute to changes in
ensory responsiveness?
TRPV1 levels decrease substantially in injured noci-
eptor neurons after peripheral axonal injury, but they
ncrease in neighboring noninjured neurons. This in-
ludes novel expression in large low-threshold A fiber
eurons, a phenotype shift that may contribute to neu-
opathic pain (Hudson et al., 2001). An increase in
RPV1 expression despite unchanged mRNA levels oc-
urs in primary sensory neurons after peripheral inflam-
ation and requires retrograde transport of nerve
rowth factor (NGF) and activation of p38 mitogen-acti-
Minireview
11vated protein kinase (MAPK) (Ji et al., 2002). Moreover,
protein kinase C (PKC) activation induces rapid delivery
of TRPV1 channels to the cell membrane, contributing
to the sensitizing effect of this kinase on TRPV1 (More-
nilla-Palao et al., 2004). Increases in the trafficking of
TRPV1 to the periphery contribute to inflammatory pain
hypersensitivity (Ji et al., 2002).
In the early phase of inflammation, increased pain
sensitivity originates largely as a result of the local re-
lease from inflammatory cells of a number of mediators.
Most of these inflammatory mediators do not directly
activate nociceptors, but rather act as sensitizers, re-
ducing the threshold of the peripheral nociceptor ter-
minals. Among the major inflammatory mediators are
prostanoids, particularly prostaglandin E2 (PGE2), bra-
dykinin, and NGF. These chemicals acting through EP
prostaglandin and B1/B2 bradykinin G protein-coupled
receptors and the high-affinity TrkA NGF receptor pro-
duce their immediate effects on pain hypersensitivity
locally on the nociceptor terminals by phosphorylating
TRPV1 as well as the sensory neuron-specific voltage-
gated sodium channel Nav 1.8. Activation of the prote-
ase-activated receptor 2 (PAR2) by inflammatory prote-
ases like trypsin has a similar effect. Phosphorylation
and dephosphorylation substantially alter TRPV1 ion
channel function, and this represents a major means of
rapidly and dynamically altering pain sensitivity (Fig-
ure 1).
Although NGF directly sensitizes nociceptors by
increasing TRPV1 activity, it is not yet clear exactly how
it does this. Activation, via TrkA, of phospholipase Cγ
(PLCγ) hydrolyzes phosphatidylinositol 4,5-bisphos-
phate (PIP2). PIP2 serves as a tonic TRPV1 channel in-
hibitor, and its hydrolysis releases this inhibition (Chu-
ang et al., 2001). Hydrolysis of PIP2 also releases
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
(DAG), which activate PKC, leading to TRPV1 phos-
phorylation. NGF may also potentiate TRPV1 by activa-
ting PI3K (Zhuang et al., 2004) either via calmodulin-
dependent kinase II (CaMKII), PKC, or ERK (Zhuang et
al., 2004). In one study, neither ERK nor PKC but rather
PKA coupled NGF to TRPV1 (Shu and Mendell, 2001).
Bradykinin (BK) may, like NGF, release the inhibitionFigure 1. Scheme of the Major Signaling
Pathways that Regulate TRP Ion Channels
(+) represents sensitization or activation; (−)
represents desensitization. See text for de-
tails.of TRPV1 by PIP2 as well as activate PKC to phospho-
rylate TRPV1 and in this way sensitize the receptor
(Sugiura et al., 2002). The B2 receptor also couples to
phospholipase A2 (PLA2), which produces arachidonic
acid (AA), which can be converted to 12-hydroperoxyei-
cosatetraenoic acid (12-HPETE) by 12-lipoxygenase
(LOX). HPETE activates TRPV1 (Shin et al., 2002). Inhi-
bition of PLC, PKC, PLA2, and lipoxygenase reduce pe-
ripheral BK-induced nociception (Ferreira et al., 2004).
BK also activates TRPA1 in a PLC-dependent manner
(Bandell et al., 2004).
PGE2, another product of arachidonic acid, is cata-
lyzed by cyclooxygenase (COX), the COX-2 isomer of
which is highly induced in inflammatory cells. PGE2
sensitizes TRPV1 via PKA (Hu et al., 2002) and also sen-
sitizes TRPV4. Inhibition of COX-2 at the site of periph-
eral inflammation is likely to be one of the means by
which COX-2 inhibitors produce analgesia, although a
central action contributes as well. Epoxyeicosatrienoic
acids (EET), arachidonic acid metabolites converted by
cytochrome P450 (P450), directly activate TRPV4 (Wa-
tanabe et al., 2003).
Diverse studies on different inflammatory mediators
report multiple and sometimes contradictory effects on
TRPs that occur via different signaling pathways. Al-
though experimental factors may contribute, the appar-
ent diversity in observed effects may be real. Specificity
in vivo might rely on a highly-ordered subcellular local-
ization of the TRPs in membrane microdomains in
which all components of a particular signaling process
are physically confined to a spatially restricted sub-
compartment of the cell. The physical proximity of the
elements of the microdomain is maintained by sub-
membrane scaffolding proteins, preventing signals
from diffusing and ensuring a specific outcome to a
particular ligand exposed at a particular time to a par-
ticular site. Given the multiplicity of pathways that act
on TRPV1 to potentiate or desensitize the channel,
microdomains may retain order while enabling com-
plexity and flexibility. A kinase anchoring protein
(AKAP), an anchoring molecule critical for formation of
microdomains, is required for the potentiation of TRPV1
by PKA (Rathee et al., 2002). In addition, in superior
Neuron
12Ccervical ganglion neurons, the microdomain formed by
Pthe B2 receptor, G proteins, PLCβ, and the IP3 receptor,
(along with TRPC1, is delimited by an actin scaffold that
Csupports the IP3 receptor in a position close to the b
plasma membrane, allowing specific signaling from the
C
B2 receptor to TRPC1 and opening of the channel (Del- (
mas et al., 2002).
C
TRPV1 can be both sensitized and desensitized. Sen- V
sitized TRPV1 contributes to heat pain hypersensitivity. A
However, prolonged application of capsaicin induces a D
desensitization of TRPV1 that leads to analgesia, and B
topical capsaicin is used to treat patients with posther- F
1petic neuralgia. TRPV1 desensitization is calcium de-
pendent and may be mediated by calmodulin (CaM), H
7which directly interacts with calmodulin binding sites
Hpresent on several TRPs (Lambers et al., 2004). How-
Wever, while one group finds that calmodulin alters open
Jchannel probability to promote desensitization and that
Ncalmodulin mutants inhibit desensitization (Rosenbaum
Jet al., 2004), another reports that both calmodulin inhib-
Pitors and loss-of-function mutants fail to prevent de-
2
sensitization (Numazaki et al., 2003).
J
Is sensitization and desensitization of TRPV1 a func- O
tional reflection of the balance between phosphoryla- L
tion and dephosphorylation? Phosphorylation of d
TRPV1 by CaMKII appears to be critical for its sensiti- M
zation, and dephosphorylation by calcineurin (phos- S
(phatase 2B or PP2B, a calcium-dependent protein
phosphatase) appears to be critical for its desensitiza- M
rtion (Jung et al., 2004). However, since the calcium/cal-
Nmodulin complex activates both CaMKII and calcineu-
Hrin, how does it drive two completely opposite effects?
8Future work is needed to illuminate whether it is a
Rmatter of timing, calcium concentration, or different
Wcalcium binding sites that determines facilitation or in-
4
activation of TRPV1.
RConclusions (
Progress in TRP sensory biology has been phenomenal R
since David Julius and Michael Caterina cloned the M
capsaicin receptor (then known as VR1) and recognized S
that it was a TRP channel (TRPV1). TRPs clearly play a S
Sprime role as molecular sensors for an increasingly var-
ied and complex set of sensory stimuli. Many questions S
remain, though. Is the reduction in TRPV1 thermal S
Nthreshold sufficient to drive spontaneous activity in
nociceptors in response to body temperature and T
1thereby drive spontaneous pain? Will TRPV1 receptor
Vantagonists be clinically useful analgesics? What is the
Vrole of TRPV2, whose temperature threshold (>50°C) is
Whigher than any sensory neuron is ever likely to see?
2Are any of the TRPs the missing pinch pain detectors?
WHow exactly are channel activities fine-tuned to ensure
Jaccurate sensing of a changing environment? Sensory
Wbiologists, clinicians, patients, and even gourmands all
N
eagerly await further developments in this exciting
W
pain trip. K
(
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